Introduction: Diabetes is a chronic disorder and requires longterm therapy. Lack of adherence to antidiabetic medication causes suboptimal glycemic control and can lead to treatment failures, development of complications, and increased mortality.
INTRODUCTION
Diabetes mellitus is one of the most common chronic diseases across the world, and the number of diabetic patient is on the rise. In 2011, there were 366 million people with diabetes globally, and this is expected to rise to 552 million by 2030. 1 It has been shown unequivocally that good glycemic control helps to prevent diabetic complications. 2, 3 In recent years, newer antidiabetic drugs have been introduced to optimally control diabetes, which have increased the complexity of diabetes treatment algorithms leading to multiple second-line and third-line options. [4] [5] [6] [7] Nonadherence to medication declines the efficacy of the medication and, in turn, the glycemic control. 8 Adherence is referred as active, voluntary, and collaborative involvement of the patient in a mutually acceptable course of behavior to produce a therapeutic result. [9] [10] [11] [12] Adherence to antidiabetic medications has been shown to improve glycemic control, and predicts good long-term prognosis of the disease. 13, 14 Medication adherence to antidiabetic agents has also been shown to be more cost-effective, as it may reduce hospitalization frequency and costs associated with complications. 15, 16 Worldwide, studies on medication adherence among diabetic patients have shown a wide variation. [17] [18] [19] [20] [21] [22] [23] [24] In India, [25] [26] [27] Limited studies from Southern and Northern regions of India have documented wide variation in the medication adherence and have addressed the issues of nonadherence in diabetic patients. 21, [28] [29] [30] [31] [32] [33] AIM Therefore, this study was conducted to assess the medication adherence among type II diabetic patients attending a tertiary care hospital in Navi Mumbai, India.
MATERIALS AND METHODS
A cross-sectional, observational study was conducted in the Outpatient Diabetology Clinic, MGM Hospital, Navi Mumbai, Maharashtra, India, from October 2014 to September 2015. Ethical clearance was obtained from the Institutional Ethics Committee.
Adult patients diagnosed with type II diabetes taking antidiabetic drug therapy for more than 6 months attending Diabetology Clinic were included and interviewed. After taking informed consent, patients were interviewed in the adjacent room. Their demographic data along with details of duration of treatment, current antidiabetic drug therapy, and medication adherence were recorded. Fasting and postprandial blood glucose was measured by Accu-Chek Active Glucometer. The study excluded type I diabetics, newly diagnosed type II diabetic patients on antidiabetic drug treatment for less than 6 months, and diabetics not willing for informed consent and/or blood glucose measurement. Participants were further categorized as having optimal controlled glycemic level based on the blood glucose level (fasting <130 mg/dL and/or postprandial <180 mg/dL).
To assess the medication adherence, The scale is designed to facilitate identification of barriers to and behaviors associated with adherence to medication. It is a self-report questionnaire with eight questions (items) having good validity and internal reliability. Response categories are yes/no for each item with a dichotomous response and a 5-point Likert response for the last item. Based upon the responses, each item is scored and a total score is calculated. Scores on the MMAS were categorized as: 0 to 6 = low, 6 = medium, and 7 to 8 = high.
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Statistical Analysis
Data recorded were entered in Microsoft Excel version 2007. Statistical analysis was done using Statistical Package for the Social Sciences version 20. Data were expressed in actual number, mean ± standard deviation (SD), and percentage; t-test was used to compare the mean between the two groups. Probability p-value of less than 0.05 was considered as statistically significant.
RESULTS
A total of 100 type II diabetic patients were included and analyzed. The mean age of the sample was 54 (±10.3) years and male:female ratio was 65:35 ( Table 1) . Responses of the study participants to individual items of MMAS-8 are summarized in Table 2 .
Responses of patients were analyzed; 83% said they forgot to take medicines when away from home and/ or traveling; 69% complained of inconvenience and difficulty in adhering to medication plan; 50% said they just forget to take medicines. In this study, based upon the total MMAS score, only 1% had perfect/high medication adherence, while 34% had moderate and 65% had low medication adherence (Table 3) . Type II diabetic patients were further analyzed based upon glycemic status. We found that only 19% were having controlled blood glucose, whereas 81% were having uncontrolled blood glucose despite being on drug therapy. On subgroup analysis, MMAS score was higher in controlled group in comparison with uncontrolled group, but this difference was not statistically significant (Table 4) .
DISCUSSION
The findings of the study suggest that the medication adherence was low and addresses the issue of nonadherence among type II diabetic patients. Worldwide studies using various research assessment instruments and systematic reviews have addressed issues of poor medication adherence among diabetes patients. [17] [18] [19] [20] [21] [22] 37 In this study, medication adherence was assessed using MMAS-8. It is a reliable and validated scale. The scale is designed to facilitate identification of barriers to and behaviors associated with adherence to medication. [34] [35] [36] Only 1% had high while 34% had moderate and 65% had low medication adherence. It was observed that many patients forgot to take medicines with them while traveling. Some of them stopped taking medicines on their own because they believed that their diabetes was under control. Others felt it was difficult to stick to a prescribed treatment plan and so stopped medication. The findings are comparable to several Indian studies documenting poor medication adherence in diabetic patients. 21, 28, 29, 38 Sharma et al 21 documented that only 16.6% of the patients were adhering to the prescribed antidiabetic drugs, and majority often forgot to take antidiabetic medications. Nonadherence was high and significantly (p < 0.001) associated with frequent dosing and multiple drugs in the prescription, especially attributed to the "forgetfulness" in the older/occupationally retired age groups. Patients would deliberately take drug holidays without the knowledge of their physician. More than half of the patients desired a decrease in the number and the frequency of medications. More than 50% of patients were not aware of the consequences of missing the drugs; 13.3% of patients experienced a number of side effects contributing to medication nonadherence (p < 0.05). Study conducted by Shaimol et al 28 (Kerala) reported that only 21.8% of patients showed high adherence, 43.3% moderate adherence, and 35.3% low adherence toward the therapy. The study concluded that among educated patients, medication adherence is higher. Study described that low-income patients were less adherent to the prescribed therapy than high-income patients. The patients with onset of diabetes at younger age showed more adherence to treatment than older patients. Study conducted by Khan et al 29 also documented that only 9.8% diabetic had high adherence. Majority of the diabetic patients were on three-drug combination and showed poor glycemic control with poor compliance to drug therapy. However, some studies have documented better medication adherence than our study. [30] [31] [32] [33] Priyanka et al 30 documented that majority (60%) had high medication adherence, and this high medication adherence rates were regardless of number of medicines prescribed. Majority of diabetics had positive beliefs about the necessity of their medication and this may have resulted in high adherence. Similarly Baishnab et al 31 recorded that the adherence levels were 64.90% (high adherence), 29.80% (medium adherence), and 5.29% (poor adherence). The most common reasons for nonadherence were the patient feeling better, cost of medications being expensive, and high quantity of medications. Similarly, the study undertaken by Sajith et al 32 (in Maharashtra) found that the adherence levels were high (40.95%), medium (37.14%), and poor (21.90%) among diabetic patients. Arulmozhi and Mahalakshmy 33 chronicled that 49.8% were high, 24.7% moderate, and 26% low adherent. This better medication adherence probably could be explained by increased awareness about diabetes mellitus and its complications among the population. They substantiated that poor family support was a significant factor associated with low medication adherence and emphasized to assess patients regularly for medication adherence and also include their families in counseling sessions. Secondary analysis revealed that only 19% type II diabetics were having glycemic level optimally controlled, whereas 81% were having uncontrolled glycemic levels. Indian studies have shown that more than 50% of people with diabetes have poor glycemic control, and this is a growing concern. In this study, the medication adherence scores were comparatively lower in type II patients with uncontrolled glycemic levels than those having optimally controlled glycemic levels, reflecting lower medication adherence in type II diabetics with uncontrolled levels, but this difference was not statistically significant. Glycemic control can be influenced by multiple factors, namely dietary adherence, regular physical activity, and appropriate drug therapy, of which antidiabetic drug therapy plays an important role. As adherence to medication declines, efficacy and glycemic control also decrease. 8 Therefore, adherence to medication is an essential component in diabetic care management. Adherence could be affected by patient-centric, physician-dependent, or health care establishment factors. Physicians can play a major role in improving medication adherence by increasing interaction with patients. The physician-patient relationship plays a major role in keeping the patient well informed about the medications they consume. Patients' adherence, when the treatment regimen is simple, seems effective. If they believe the benefits exceed the costs and that their environment supports regimen-related behaviors, their medication adherence improves. 39 Diabetes is a chronic disorder which requires lifelong compliance with treatment regime. Efforts should be made by the physicians to identify the reasons for nonadherence and initiate steps to improve it. They need to educate and counsel the patients on the importance of medication adherence and self-care activities in order to achieve optimal glycemic control.
LIMITATIONS
The study sample size was limited. As it was conducted at a single tertiary care hospital, the findings cannot be generalized to the community. Glycosylated hemoglobin is the gold standard but due to financial restraint, only blood glucose measurements by glucometer were used. Dietary, lifestyle modifications, and physical activityrelated factors were not addressed. Further multicentric hospital and community-based studies with larger sample size are warranted. Medication adherence was assessed using MMAS-8, a self-reported scale likely to be affected by recall bias and error in self-observation.
CONCLUSION
Overall, the medication adherence was low in type II diabetic patients. There is a need to address the issue of nonadherence to medication. Efforts should be made by physicians to identify the reasons for nonadherence and initiate steps to improve it. Counseling and health education of the patients related to medication adherence need to be improved.
